REFERENCES
- Bagnato, A., & Catt, K. J. (1998). Endothelin as autocrine regulators of tumor cell growth. Trends in Endocrinology and Metabolism, 9, 378–383.
- Bagnato, A., Spinella, F., & Rosanò, L. (2005). Emerging role of the endothelin axis in ovarian tumor progression. Endocrine-Related Cancer, 12, 761–772.
- Battistini, B., Chailler, P., D'Orleans-Juste, P., (1993). Growth regulatory properties of endothelins. Peptides, 14, 385–399.
- Egidy, G., Eberl, L. P., Valdenaire, O., (2000). The endothelin system in human glioblastoma. Laboratory Investigation, 80, 1681–1689.
- Godara, G., Cannon, G. W., Cannon, G. M., (2005). Role of endothelin axis in progression to aggressive phenotype of prostate adenocarcinoma. Prostate, 65, 27–34.
- Kleihues, P., & Cavenne, W. K. (2000). Pathology and Genetics: Tumours of the Nervous System. Lyon: IARC; c2000, 630 p.
- Kusuhara, M., Yamaguchi, K., Nagasaki, K., (1990). Production of endothelin in human cancer cell lines. Cancer Research, 50, 3257–3261.
- Levin, E. R. (1995). Endothelins. New England Journal of Medicine, 333, 356–363.
- Li, J. M., Wu, X. L., Zhu, Q. J., (2002). Endothelin-1 expression and quantitative analysis in astrocytomas (in Chinese). Ai Zheng, 21, 1109–1111.
- Nelson, J., Bagnato, A., Battistini, B., (2003). The endothelin axis: Emerging role in cancer. Nature Reviews Cancer, 3, 110–116.
- Paolillo, M., Barbieri, A., Zanassi, P., (2006). Expression of endothelins and their receptors in glioblastoma cell lines. Journal of Neurooncology, 79, 1–7.
- Paolillo, M., Russo, M. A., Curti, D., (2010). Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells. Pharmacology Research, 61, 306–315.
- Pristivishalil, G., & Nelson, J. B. (2000). Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate, 44, 77–87.
- Schilling, H., Sehu, K. W., & Lee, W. R. (1997). A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques. Investigative Ophthalmology and Visual Science, 38, 2081–2092.
- Schinelli, S. (2006). Pharmacology and physiopathology of the brain endothelin system: An overview. Current Medicinal Chemistry, 13, 627–638.
- Starkweather, A. R., Sherwood, P., Lyon, D. E., (2011). A biobehavioral perspective on depressive symptoms in patients with cerebral astrocytoma. Journal of Neuroscience Nursing, 43, 17–28.
- Stiles, J. D., Ostrow, P. T., Balos, L. L., (1997). Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. Journal of Neuropathology and Experimental Neurology, 56, 435–439.
- Vacca, F., Bagnato, A., Catt, K. J., (2000). Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Research, 60, 5310–5317.